RPL7P61

Across TCGA pan-cancer cohorts, RPL7P61 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RPL7P61 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RPL7P61 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL7P61 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUSC show a favorable association.

UCS, KIRC, and BLCA are the cancer types where RPL7P61 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	II,III,IV	0.168	0.518	.001	90	view →
KIRC	OS	Tertile	All	0.549	0.666	<.001	85	view →
BLCA	OS	Tertile	All	0.872	0.532	.006	42	view →
CESC	DFS	Tertile	IV	0.121	0.548	.002	36	view →
UVM	OS	Tertile	All	0.549	0.749	.015	33	view →
ACC	OS	Tertile	IV	0.145	0.715	<.001	33	view →
LIHC	DFS	Tertile	II,III,IV	0.236	0.511	<.001	33	view →
THCA	OS	Tertile	IV	0.774	1.000	<.001	24	view →
SKCM	OS	Tertile	II,III,IV	0.284	0.436	.012	15	view →
SARC	OS	Tertile	All	0.660	0.850	.006	12	view →
LUSC	OS	Tertile	II,III,IV	0.733	0.570	.022	9	view →
DLBC	DFS	Tertile	II,III,IV	1.000	0.723	.032	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RPL7P61–UCS (DFS)

Open the UCS breakdown →